<html>
    <body>
<table>

<tbody>
    <tr>
        <td>Apr-12-21 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Presents Data at AACR Annual Meeting Assessing Gedatolisib, a pan-PI3K/mTOR Inhibitor,
                        in HER2-negative Breast and Ovarian Cancer Patient Tumors with Hyperactive RAS Network
                        Signaling</a></div>
                <div><span> ACCESSWIRE</span> <span>+29.35%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>09:37AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Company News for Apr 12, 2021</a></div>
                <div><span> Zacks</span></div>
            </div>
        </td>
    </tr>
    <tr></tr>
    <tr>
        <td>06:59AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity (CELC) Soars on Agreement With Pfizer &amp; Study Data</a></div>
                <div><span> Zacks</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Apr-10-21 05:13AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>15 Best Stocks in the Past Week: Square, Roku, Pinterest</a></div>
                <div><span> TheStreet.com</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Apr-09-21 04:30PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>How A Pfizer Cancer Drug Pact Launched Celcuity Stock Into A Breakout</a></div>
                <div><span> Investor's Business Daily</span> <span>+50.94%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>06:37AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Stock Moves Higher After Licensing Pact With Pfizer For Gedatolisib In Breast
                        Cancer</a></div>
                <div><span> Benzinga</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Apr-08-21 04:05PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine
                        Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update</a>
                </div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>04:02PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize
                        Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Apr-06-21 02:41AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>We're Not Very Worried About Celcuity's (NASDAQ:CELC) Cash Burn Rate</a></div>
                <div><span> Simply Wall St.</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-18-21 08:38AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Company News for Mar 18, 2021</a></div>
                <div><span> Zacks</span> <span>+5.57%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-17-21 07:43AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese
                        Biologics Unit, Celcuity Spikes</a></div>
                <div><span> Benzinga</span> <span>+9.67%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-16-21 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Breast Cancer Clinical Trial Collaboration with MD Anderson, Novartis, and
                        Puma Biotechnology to Study New Drug Regimen</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-01-21 03:30PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Closing of Common Stock Offering and Full Exercise of Underwriter's Option to
                        Purchase Additional Shares of Common Stock</a></div>
                <div><span> ACCESSWIRE</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Feb-24-21 02:02PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Raises $24M Via Upsized Equity Offering At 11% Discount</a></div>
                <div><span> Benzinga</span> <span>-8.59%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>07:30AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Prices Upsized Public Offering of Common Stock</a></div>
                <div><span> ACCESSWIRE</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Feb-22-21 08:00AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Proposed Public Offering of Common Stock</a></div>
                <div><span> ACCESSWIRE</span> <span>-6.74%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Feb-16-21 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business
                        Highlights</a></div>
                <div><span> ACCESSWIRE</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>02:30PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity, Inc. to Host Earnings Call</a></div>
                <div><span> ACCESSWIRE</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Feb-01-21 01:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2020 Financial Results and
                        Conference Call</a></div>
                <div><span> ACCESSWIRE</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Jan-28-21 08:03AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical
                        Diagnostics IPO</a></div>
                <div><span> Benzinga</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Jan-27-21 05:31PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Breast Cancer Clinical Trial Collaboration with Sarah Cannon and Pfizer to
                        Study New Drug Regimen</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Jan-19-21 02:32PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity to Present at the B. Riley Oncology Investor Conference</a></div>
                <div><span> Business Wire</span> <span>+11.03%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Jan-06-21 01:09AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>What Is The Ownership Structure Like For Celcuity Inc. (NASDAQ:CELC)?</a></div>
                <div><span> Simply Wall St.</span></div>
            </div>
        </td>
        </t…<td>
        <div>
            <div><a>What Percentage Of Celcuity Inc. (NASDAQ:CELC) Shares Do Insiders Own?</a></div>
            <div><span> Simply Wall St.</span></div>
        </div>
        </td>
    </tr>
    <tr>
        <td>Dec-11-18 08:10AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Consolidated Research: 2018 Summary Expectations for IRHYTHM TECH, ON Semiconductor, CryoPort,
                        Celcuity, InnerWorkings, and AgroFresh Solutions Fundamental Analysis, Key Performance
                        Indications</a></div>
                <div><span> GlobeNewswire</span> <span>-8.88%</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Dec-07-18 06:33PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Presents Results from Three Studies at the 2018 San Antonio Breast Cancer Symposium
                        Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and Co-Activated HER Family and
                        c-Met Signaling</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Nov-13-18 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports Third Quarter 2018 Financial Results</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Oct-31-18 08:00AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice
                        President</a></div>
                <div><span> GlobeNewswire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Oct-30-18 04:56PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. Schedules Release of Third Quarter 2018 Financial Results and Conference Call</a>
                </div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Oct-19-18 07:45AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Detailed Research: Economic Perspectives on BeiGene, Costco Wholesale, Rogers, Advance Auto
                        Parts, Celcuity, and Harris What Drives Growth in Today's Competitive Landscape</a></div>
                <div><span> GlobeNewswire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Oct-16-18 05:51PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer
                        Center</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Aug-09-18 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports Second Quarter 2018 Financial Results</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>02:30PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. to Host Earnings Call</a></div>
                <div><span> ACCESSWIRE</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Aug-02-18 04:31PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. Schedules Release of Second Quarter 2018 Financial Results and Conference Call</a>
                </div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>May-14-18 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports First Quarter 2018 Financial Results</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>May-02-18 12:28PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. Schedules Release of First Quarter 2018 Financial Results and Conference Call</a>
                </div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-19-18 07:33AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>SHAREHOLDER ALERT: Purcell Julie &amp; Lefkowitz LLP Is Investigating Celcuity Inc. for
                        Potential Breaches Of Fiduciary Duty By Its Board of Directors</a></div>
                <div><span> PR Newswire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-15-18 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports Fourth Quarter and Full Year 2017 Financial Results</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Mar-02-18 04:00PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2017 Financial Results and
                        Conference Call</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Jan-19-18 07:30AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Investor Expectations to Drive Momentum within Advanced Micro Devices, Knoll, Hubbell, Celcuity,
                        SecureWorks, and First Foundation Discovering Underlying Factors of Influence</a></div>
                <div><span> GlobeNewswire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Nov-13-17 07:00AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Reports Third Quarter Fiscal 2017 Financial Results</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Nov-02-17 01:08PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Inc. Schedules Release of Third Quarter Fiscal 2017 Financial Results and Conference
                        Call</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Oct-31-17 09:15PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Is Celcuity Incs (CELC) Balance Sheet Strong Enough To Weather A Storm?</a></div>
                <div><span> Simply Wall St.</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Sep-24-17 09:57AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>IPO News This Week: Roku, PQ Group Lead 7 Offerings Due Out</a></div>
                <div><span> 24/7 Wall St.</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Sep-22-17 04:05PM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Closing of Initial Public Offering</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
    <tr>
        <td>Sep-20-17 06:00AM&nbsp;&nbsp;</td>
        <td>
            <div>
                <div><a>Celcuity Announces Pricing of Initial Public Offering</a></div>
                <div><span> Business Wire</span></div>
            </div>
        </td>
    </tr>
</tbody>

</table>

    </body>
    
    </html>